The beginnings of radioiodine therapy of metastatic thyroid carcinoma: A memoir of Samuel M. Seidlin, M.D. (1895-1955) and his celebrated patient

Cancer Biotherapy and Radiopharmaceuticals

Volumn 14, Issue 2, 1999, Pages 71-79

  Siegel, Edward ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

CANCER PATIENT; DOSIMETRY; HISTOPATHOLOGY; HISTORY OF MEDICINE; HUMAN; METASTASIS; PHYSICIAN; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; REVIEW; THYROID CARCINOMA; THYROTROPIN RELEASE;

EID: 0032963930     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1999.14.71     Document Type: Review

References (32)

1. Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy effect on functioning metastases of adenocarcinoma of the thyroid. JAMA 1946;132:838-847.
2. Hamilton JG, Soley MH, Eichorn KB. Deposition of radioactive iodine in human thyroid tissue. Univ Calif Pubs Pharmacol 1940;1:339-368.
3. Keston AS, Ball RP, Frantz VK, Palmer WW. Storage of radioactive iodine in a metastasis from thyroid carcinoma. Science 1942;95:362-363.
4. Radioactive indicators. Hevesy G. New York: Interscience Publishers, 1948.
5. Hertz S, Roberts A, Evans, RD. Radioactive iodine as an indicator in the study of thyroid physiology. Proc Soc Exper Med Biol 1918;38:510-513.
6. Evans RD. Early history (1936-1946) of nuclear medicine in thyroid studies at Massachusetts General Hospital. Med Physics 1975;2:105-109.
7. Livingood JJ, Seaborg, GT. Radioactive iodine isotopes. Physical Rev 1938;53:1015.
8. Seidlin SM. The metabolism of the thyrotropic and gonadotrophic hormones. Enodcrinol 1940;26:696-702.
9. Leiter L, Seidlin SM, Marinelli LD, Baumann EJ. The effect of thiouracil on hyperthyroidism and on the uptake of radioactive iodine in patients with adenocarcinoma of the thyroid and functioning metastases. J Clin Invest 1944;23:941-48.
10. Leiter L, Seidlin SM, Marinelli LD, Baumann EJ. Adenocarcinoma of the thyroid with hyperthyroidism and functioning metastases. I. Studies with thiouracil and radio-iodine. J Clin Endocrinol 1946;6:247-261.
11. Seidlin SM, Rossman I, Oshry E, Siegel E. Radioiodine therapy of metastases from carcinoma of the thyroid: a six-year progress report. J Clin Endocrinol 1949;9: 1122-1137.
12. Seidlin SM. In, Radioisotopes in medicine. Andrew GA, Bracer M, Anderson EB, editors. U S Atomic Energy Commission, Washington DC; 1953, p.393.
13. Seidlin SM, Oshry E, Yalow AA. Spontaneous and experimentally induced uptake of radioactive iodine in metastases from thyroid carcinoma: a preliminary report. J Clin Endocrinol 1948;8:423-432.
14. Seidlin SM. Clinical methods and results of radioiodine therapy in metastatic thyroid cancer. Brookhaven Conference Report 1948;BNL-C-5, 106-112.
15. Seidlin SM. Radioiodine as a diagnostic and therapeutic tool in clinical medicine. Recent Progress in Hormone Research 1949;4:483-510.
16. Seidlin SM. Radioiodine in the treatment of metastatic thyroid carcinoma. Med Clins N Amer 1952;36:663-680.
17. 131 therapy for metastatic thyroid carcinoma. J Clin Endocrinol Metab 1952;12:1197-1204.
18. Seidlin SM, Yalow AA, Siegel E. Blood radiation dose during radioiodine therapy of metastatic thyroid carcinoma. Radiology 1954;63:797-813.
19. Seidlin SM, Yalow AA, Siegel E. Irradiation produced rise in blood radioiodine concentration following ingested therapeutic dose for metastatic thyroid carcinoma. Proc Soc Exp Biol Med 1951;76:711-714.
20. Seidlin SM, Siegel E, Melamed S, Yalow AA. Occurrence of myeloid leukemia in patients with metastatic thyroid carcinoma following prolonged massive radioiodine therapy. Bull N Y Acad Med 1955;31:410.
21. Seidlin SM, Siegel E, Yalow AA, Melamed S. Acute myeloid leukemia following prolonged iodine-131 therapy for metastatic thyroid carcinoma. Science 1955;123:800-801.
22. Bartelstone HJ, Mandel ID, Oshry E, Seidlin, SM. Use of radioactive iodine as a tracer in the study of the physiology of teeth. Science 1947;106:132-133.
23. Baumann EJ, Searle NZ, Yalow AA, Siegel, E, Seidlin SM. Behavior of the thyroid toward elements of the seventh periodic group. Am J Physiol 1956;185:71-76.
24. Baumann, EJ, Searle NZ, Yalow AA, Siegel E, Seidlin SM. Behavior of thyroid toward elements of seventh periodic group. III. Technetium. Fed Proc 1956;11, Part 1.
25. 131I labeled iodide, thyroxine and triiodothyronine, and its relation to thyroid function. J Clin Endocrinol Metab 1964;24:313-318.
26. Sachs BA, Siegel E, Kass S, Dolman M. Radioiodine therapy of thyrotoxicosis. Amer J Roentgnol Rad Ther Nuc Med 1972;115:698-705.
27. Sachs BA, Siegel E, Horwitt BN, Siegel EP. Bread iodine content and thyroid radioiodine uptake: a tale of two cities. Brit Med J 1972;79-81.
28. Siegel E, Sachs BA, Graig FA. Fate of radiosulfate in multiple myeloma. Proc Soc Exp Biol Med 1959;101: 53-56.
29. 35S-cystine in multiple myeloma. Brit J Cancer 1960:14:730-736.
30. Sachs BA, Siegel E, Marino JV. Early incorporation of sulphur-35 sodium sulphate into plasma proteins of man. Nature 1960;188:1125-1127.
31. 65 in man. Proc Soc Exper Biol Med 1960;104:391-394.
32. 65Zn in the prostate and other organs of man. Brit J Cancer 1961;15:647-664.